Detecting ALK , ROS1, and RET fusions and the METΔex14 splicing variant in liquid biopsies of non‐small‐cell lung cancer patients using RNA‐based techniques

ALK, ROS1, and RET fusions and MET∆ex14 variant associate with response to targeted therapies in non‐small‐cell lung cancer (NSCLC). Technologies for fusion testing in tissue must be adapted to liquid biopsies, which are often the only material available. In this study, circulating‐free RNA (cfRNA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Giménez‐Capitán, Ana, Sánchez‐Herrero, Estela, Robado de Lope, Lucía, Aguilar‐Hernández, Andrés, Sullivan, Ivana, Calvo, Virginia, Moya‐Horno, Irene, Viteri, Santiago, Cabrera, Carlos, Aguado, Cristina, Armiger, Noelia, Valarezo, Joselyn, Mayo‐de‐las‐Casas, Clara, Reguart, Noemí, Rosell, Rafael, Provencio, Mariano, Romero, Atocha, Molina‐Vila, Miguel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483610/
https://www.ncbi.nlm.nih.gov/pubmed/37243883
http://dx.doi.org/10.1002/1878-0261.13468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483610/
https://www.ncbi.nlm.nih.gov/pubmed/37243883
http://dx.doi.org/10.1002/1878-0261.13468

Ejemplares similares